X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,807 | -41,970 | -24,256 | -10,873 | -33,285 |
| Depreciation Amortization | 103 | 71 | 44 | 20 | 103 |
| Accounts payable and accrued liabilities | -2,752 | -3,131 | -1,702 | 1,332 | 1,307 |
| Other Working Capital | -3,236 | -3,976 | -3,243 | -1,536 | 3,135 |
| Other Operating Activity | 10,637 | 10,192 | 3,115 | -693 | 3,320 |
| Operating Cash Flow | $-48,055 | $-38,814 | $-26,042 | $-11,750 | $-25,420 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 826 | 805 | -10 | N/A | N/A |
| Net Acquisitions | 26,406 | 26,406 | 26,406 | 26,406 | N/A |
| Investing Cash Flow | $27,232 | $27,211 | $26,396 | $26,406 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,849 | 9,849 | 9,849 | 0 | 9,908 |
| Debt Repayment | -9,368 | -9,368 | -2,914 | N/A | -6,380 |
| Common Stock Issued | 140,180 | 79,896 | 79,856 | 113 | 7 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 3,335 |
| Financing Cash Flow | $140,661 | $80,377 | $86,791 | $113 | $6,870 |
| Exchange Rate Effect | -250 | -266 | -2 | -21 | N/A |
| Beginning Cash Position | 8,498 | 8,498 | 8,498 | 8,498 | 27,048 |
| End Cash Position | 128,086 | 77,006 | 95,641 | 23,246 | 8,498 |
| Net Cash Flow | $119,588 | $68,508 | $87,143 | $14,748 | $-18,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,055 | -38,814 | -26,042 | -11,750 | -25,420 |
| Capital Expenditure | -174 | -91 | -10 | N/A | N/A |
| Free Cash Flow | -48,229 | -38,905 | -26,052 | -11,750 | -25,420 |